-
Eli Lilly to buy Loxo Oncology for $8 billion
expressbpd
January 10, 2019
The deal follows Bristol-Myers Squibb Co agreement last week to buy Celgene Corp for $74 billion, and gives Lilly access to Loxo’s portfolio of targeted medicines that treat cancers caused by rare gene mutations
-
Forbius Announces the First Patient Dosed in a Phase 1 Oncology Trial of AVID200
americanpharmaceuticalreview
January 10, 2019
Forbius announced the first patient was dosed in a Phase 1 clinical trial with AVID200. The trial will evaluate safety, pharmacokinetics, pharmacodynamics, and antitumor effects of escalating doses of AVID200 in patients with solid tumors.....
-
AstraZeneca Announces Organizational Changes
americanpharmaceuticalreview
January 08, 2019
AstraZeneca has announced organizational changes that include the arrival of oncology scientist, José Baselga.Other changes include the creation of .....
-
Ex-Novartis Oncology CEO Liz Barrett joins UroGen
fiercebiotech
January 04, 2019
Ex-Novartis Oncology CEO Liz Barrett has joined UroGen Pharma. Barrett is taking over as CEO of the uro-oncology specialist at a time when it is working on a rolling NDA that could lead to its first drug approval.....
-
Relay adds executives to its chemistry, R&D teams as it transitions to the development stage
fiercebiotech
January 02, 2019
Former Fierce 15 winner Relay Therapeutics has brought on Verastem’s Mahesh Padval, Ph.D., and Eli Lilly’s Mary Mader, Ph.D., to boost its drug discovery and development operations in oncology as it begins to transition to an R&D-stage biotech.....
-
Mission Bio reels in $30M for single-cell genomics tech for oncology, CRISPR
fiercebiotech
December 26, 2018
Since launching at the end of 2017 with a focus on blood cancers, Mission Bio has built out its single-cell genomics platform to include custom offerings....
-
Lilly lays out sunny 2019 forecast driven by growth of new diabetes, psoriasis and cancer drugs
fiercepharma
December 25, 2018
Shares of Eli Lilly were up nearly 3% in premarket trading on Wednesday after the company provided a revenue and profit forecast for next year that beat analysts’ expectations.
-
AVEO Oncology Announces Clinical Collaboration with AstraZeneca
americanpharmaceuticalreview
December 24, 2018
AVEO Oncology has entered into a clinical collaboration with AstraZeneca to evaluate the safety and efficacy of AstraZeneca's Imfinzi (durvalumab).....
-
Novartis oncology CEO quits after less than a year
pharmaphorum
December 21, 2018
Novartis has appointed Susanne Schaffert to lead its oncology division after incumbent CEO Liz Barrett decided to leave for another job.
-
Novartis Announces New CEO of Oncology Business Unit
americanpharmaceuticalreview
December 21, 2018
Novartis announced Susanne Schaffert, Ph.D., currently President, Advanced Accelerator Applications (AAA), a Novartis company, has been appointed CEO Novartis Oncology.....